Keyword Connections

immune checkpoint

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

37

1 immune checkpoints, their control by immunotherapy and ovarian cancer

2 association between cd47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer

3 Novel cuproptosis-related lncRNAs risk model to predicting prognosis and guiding immunotherapy for OSCC patients.

4 Exclusive Cutaneous and Subcutaneous Sarcoidal Granulomatous Inflammation due to Immune Checkpoint Inhibitors: Report of Two Cases with Unusual Manifestations and Review of the Literature

5 Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

6 PD-L1 expression in tumour microenvironment supports the rationale for immune checkpoint blockade in classic Kaposi's sarcoma

7 Myocarditis following the use of different immune checkpoint inhibitor regimens: A real-world analysis of post-marketing surveillance data.

8 Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors.

9 Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting.

10 Multifunctional polymeric micelle-based chemo-immunotherapy with immune checkpoint blockade for efficient treatment of orthotopic and metastatic breast cancer

11 Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint

12 Atypical Presentations and Management of Endocrine and Hepatic Immune-Related Adverse Events From Adjuvant Immune Checkpoint Inhibitor Therapy in Stage III Resected Melanoma.

13 Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patients.

14 Next generation of anti-immune checkpoints antibodies

15 Association of Steroids use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

16 miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy.

17 Rapamycin and hydroxychloroquine combination alters macrophage polarization and sensitizes glioblastoma to immune checkpoint inhibitors

18 Immune-related pneumonitis associated with immune checkpoint inhibitors in lung cancer: a network meta-analysis.

19 Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?

20 IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression

21 seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma

22 inhibition of immune checkpoints and vascular endothelial growth factor as combination therapy for cancer: an overview of rationale, preclinical evidence, and initial clinical data

23 immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an “innocent bystander”

24 nuclear molecular imaging strategies in immune checkpoint inhibitor therapy

25 immune checkpoint targets for host-directed therapy to prevent and treat leishmaniasis

26 Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality

27 Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy

28 Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer

29 Immune-Related Adverse Events in the Older Adult with Cancer Receiving Immune Checkpoint Inhibitor Therapy.

30 Correction to: Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor (Advances in Therapy, (2023), 40, 9, (3599-3609), 10.1007/s12325-023-02513-1)

31 Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor

32 Immune Checkpoint Inhibitors in Geriatric Oncology.

33 Immune checkpoint therapy modeling of PD-1/PD-L1 blockades reveals subtle difference in their response dynamics and potential synergy in combination

34 Immune checkpoint inhibitor therapy as a neoadjuvant treatment for muscle-invasive bladder carcinoma: A narrative review.

35 Incidences of pneumonitis associated with the combination of radiotherapy and immune checkpoint inhibitors in lung cancer: a systematic review and meta-analysis.

36 Immune checkpoint therapy modeling of PD-1/PD-L1 blockades reveals subtle difference in their response dynamics and potential synergy in combination

37 Tumor-draining lymph nodes - friend or foe during immune checkpoint therapy?